Glenmark's Game-Changing Move: Epinephrine Injection Launch Injects New Life into US Portfolio

Unknown Apr 02, 2026 3 Views

Glenmark Pharmaceuticals Inc., USA has unveiled its latest pharmaceutical breakthrough: Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) Multiple-Dose Vial. This strategic launch, announced on February 27, 2025, not only expands Glenmark's critical care offerings but also secures a 180-day co...

Stay Ahead – Explore Now! Almost a Rockstar: Diana Penty Reveals the Role That Got Away